The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2017

Filed:

Mar. 25, 2011
Applicants:

Minnie M. Sarwal, Portola Valley, CA (US);

Tara Sigdel, Palo Alto, CA (US);

Amit Kaushal, Los Altos, CA (US);

LI LI, Fremont, CA (US);

Wenzhong Xiao, San Jose, CA (US);

Atul J. Butte, Menlo Park, CA (US);

Purvesh Khatri, Stanford, CA (US);

Inventors:

Minnie M. Sarwal, Portola Valley, CA (US);

Tara Sigdel, Palo Alto, CA (US);

Amit Kaushal, Los Altos, CA (US);

Li Li, Fremont, CA (US);

Wenzhong Xiao, San Jose, CA (US);

Atul J. Butte, Menlo Park, CA (US);

Purvesh Khatri, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C12Q 1/6809 (2013.01); C12Q 1/6883 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/245 (2013.01);
Abstract

Aspects of the present invention include methods for determining a transplant category of a subject having a transplant. Common mechanisms of rejection injury are uncovered across different tissue transplants, and provide a means to understand rational drug design. Various sources of tissues are examined form the patient for understanding AR mechanism (graft biopsy), as well as monitoring by minimal invasive means (blood) or non-invasive means (urine for the kidney allograft). For biomarker discovery different categories of markers are examined such as genes, proteins, peptides and antibodies. These biomarkers can help determine the subject's transplant category (e.g., acute allograft rejection (AR), stable allograft (STA), BK viremia, BK nephritis, drug toxicity or chronic allograft injury (CAI), and the like). Also provided are compositions, systems, kits and computer program products that find use in practicing the subject methods. The methods and compositions find use in a variety of applications.


Find Patent Forward Citations

Loading…